Liatsikos Evangelos, Bynens Bernard, Rabenalt Robert, Kallidonis Panagiotis, Do Minh, Stolzenburg Jens-Uwe
Department of Urology, University of Patras, Patras, Greece.
J Endourol. 2008 Oct;22(10):2295-8. doi: 10.1089/end.2008.9713.
To evaluate the feasibility and efficacy of salvage endoscopic extraperitoneal radical prostatectomy (EERPE) in recurrent prostate cancer after failed high intensity focused ultrasound therapy (HIFU), external beam radiotherapy (EBT) and brachytherapy.
Twelve patients with mean age 63.3 years (48-74), mean preoperative PSA 12.7 ng/ml and mean prostate weight 48.8 grams were treated with salvage EERPE with curative intent for biopsy proven locally recurrent prostate cancer. Our group was consisted of four patients who have been treated in the past with HIFU, six with EBT and two with brachytherapy. Operative time, estimated blood loss, conversion to open surgery rate, transfusion rate and transurethral catheter time were recorded. Also functional outcome and short term oncological outcome were reviewed.
Average operative time was 153 minutes. Mean blood loss was 238 ml. The procedure was completed in all cases with no difficulty and without intraoperative complications. There was no need for conversion to open surgery or transfusion. Mean total urethral catheterization time was 7.2 days. After mean follow-up of 20 months, 10 patients were completely continent, and 2 needed 1-2 pads per day. Three patients were potent before the surgical treatment, but no one reported potency postoperatively. Biochemical recurrence was observed in only one patient 12 months postoperatively.
In the initial experience, salvage EERPE in experienced hands has minimal perioperative morbidity. Short term oncological and functional outcomes are encouraging but further studies and longer follow-up are required in order to assess the long-term outcomes.
评估挽救性内镜下腹膜外根治性前列腺切除术(EERPE)在高强度聚焦超声治疗(HIFU)、外照射放疗(EBT)及近距离放射治疗失败后的复发性前列腺癌中的可行性及疗效。
12例平均年龄63.3岁(48 - 74岁)、术前平均前列腺特异抗原(PSA)为12.7 ng/ml、平均前列腺重量48.8克的患者,因活检证实为局部复发性前列腺癌而接受了以治愈为目的的挽救性EERPE治疗。我们的研究组包括4例既往接受过HIFU治疗的患者、6例接受过EBT治疗的患者及2例接受过近距离放射治疗的患者。记录手术时间、估计失血量、转为开放手术率、输血率及经尿道留置导尿管时间。同时回顾功能结局及短期肿瘤学结局。
平均手术时间为153分钟。平均失血量为238毫升。所有病例手术均顺利完成,无术中并发症。无需转为开放手术或输血。平均总尿道导尿时间为7.2天。平均随访20个月后,10例患者完全控尿,2例患者每天需要1 - 2片尿垫。3例患者在手术治疗前性功能正常,但术后无人报告性功能正常。仅1例患者在术后12个月出现生化复发。
在初步经验中,有经验的医生进行挽救性EERPE时围手术期发病率极低。短期肿瘤学及功能结局令人鼓舞,但需要进一步研究及更长时间的随访以评估长期结局。